Change of CFO at Bristol-Myers

Bristol-Myers Squibb
has selected Jean-Marc Huet, veteran finance director from Amsterdam-based baby
food supplier Royal
, to replace chief financial officer (CFO) Andrew Bonfield who will be
leaving the company ‘to seek new career opportunities’.

The change which will take place on March 31 and comes one month after the
pharmaceutical company reported an ‘impairment charge’ of $275m in auction rate
securities, consisting in part of sub-prime mortgages for the fourth quarter,
according to

Huet, who is credited with initiating and developing Numico’s acquisition
strategy, including its acquisition by Groupe Danone, will be responsible for
directing and managing the Bristol-Myers’s fiscal operations and the global
financial operations of the organisation and its subsidiaries.

Bonfield has been at Bristol-Myers since September 2002, and was responsible
for the company’s worldwide finance operation, including tax, treasury, control,
investor relations, internal audit, financial shared services, global strategic
sourcing, and information management.

the story in

Related reading